Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats

This publication has 10 references indexed in Scilit:

• Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats
  European Journal of Pharmacology, 1991
• Properties of Novel Aldose Reductase Inhibitors, M16209 and M16287, in Comparison with Known Inhibitors, ONO-2235 and Sorbinil.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
• Effects of Novel Hydantoin Derivatives with Aldose Reductase Inhibiting Activity on Galactose-Induced Cataract in Rats
  The Japanese Journal of Pharmacology, 1990
• Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects
  Diabetes, 1987
• Hypoglycemic activity of aldose reductase inhibitor, 1-((p-bromophenyl)sulfonyl)hydantoin.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
• Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas
  Diabetes, 1983
• Islet secretion in a new experimental model for non-insulin-dependent diabetes
  Diabetes, 1981
• Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia
  Diabetes, 1981
• The Pharmacology of a New Hypoglycaemic Agent N‐[4‐(2‐(2,3‐dihydrobenzo(b)furan‐7‐carboxamido)‐ethyl) ‐benzenesulphonyl] ‐N’‐cyclohexylurea (NOVO CS 476). I. Pharmacological Studies on the Hypoglycaemic effect
  Acta Pharmacologica et Toxicologica, 1977
• Studies on the Dynamics and Mechanism of Glibenclamide-Induced Insulin Secretion
  Hormone and Metabolic Research, 1976